Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
fda
life sciences
national blog main
national top stories
2
×
abbvie
alkermes
allergan
boston blog main
boston top stories
buprenorphine
cariprazine
clinical trials
drugs
eli lilly
entrepreneurship
europe
europe blog main
europe top stories
felipe jain
gail naughton
hair growth
hair regrowth
hair stimulation complex
histogen
innovation
investigational new drug (ind)
jess fiedorowicz
jessica jeffrey
karim calis
lumateperone
m health fairview
marc goodman
massachusetts general hospital
national institutes of health (nih)
olanzapine
opioid
ottawa hospital
people
regenerative medicine
What
fda
2
×
medicine
2
×
treatment
2
×
alkermes
antipsychotic
benefits
caveats
cells
cleared
clinical
commonly
company
cosmeceutical
designed
diego’s
drug
effect
favor
female
gain
gi
hair
histogen
loss
nascent
offer
panel
prescribed
produce
products
psyche
regenerative
san
skin
technology
testing
using
vote
weighs
weight
Language
unset
Current search:
fda
×
treatment
×
medicine
×
" national top stories "
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
6 years ago
Histogen Treatment for Female Hair Loss Cleared for Clinical Testing
